JamesMatthewLutherMDMSCI
Nephrology • Nashville, TNHypertension, Renovascular Medicine
Associate Professor of Medicine and Pharmacology
Dr. Luther is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3353Fax+1 615-936-0605
Summary
- Dr. James M. Luther is Associate Professor of medicine and pharmacology at Vanderbilt University School of Medicine in Nashville, Tennessee. The focus of his translational research program is to investigate the pathophysiologic links between hypertension and metabolic complications. His clinical focus in the Vanderbilt Hypertension Clinic is to evaluate and treat resistant and secondary hypertension. He is board certified in Medicine and Nephrology.
Dr. Luther received his MD degree from Vanderbilt School of Medicine, where he also completed training in Internal Medicine, Clinical Pharmacology, and Nephrology before joining the faculty in the Division of Clinical Pharmacology. He also received a Masters in Clinical Investigation program at Vanderbilt, and now serves as faculty in the program.
Education & Training
Vanderbilt Univ Med Ctr2007 - 2008- Vanderbilt Univ Med Ctr2005 - 2007
Vanderbilt University Medical CenterResidency, Internal Medicine, 2001 - 2004
Vanderbilt University School of MedicineClass of 2001
Certifications & Licensure
TN State Medical License 2003 - 2025
AL State Medical License 2020 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Clinical Trials
- Aldosterone and Glucose Homeostasis Start of enrollment: 2008 Sep 01
- Aldosterone and the Metabolic Syndrome Start of enrollment: 2010 Mar 01
- Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsThe bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistanceMias Pretorius, James V. Gainer, G P Van Guilder, Eduardo Barbosa Coelho, James M. Luther
Clinical Pharmacology and Therapeutics. 2008-01-01 - 48 citationsAldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial.Luke J Laffin, David Rodman, James M Luther, Anand Vaidya, Matthew R Weir
JAMA. 2023-09-26 - 48 citationsComparative Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin-Receptor Blockade on Inflammation during HemodialysisJorge L. Gamboa, Mias Pretorius, Deanna R. Todd-Tzanetos, James M. Luther, Chang Yu
Journal of the American Society of Nephrology. 2012-02-01
Books/Book Chapters
Press Mentions
What's Your Approach? MRAs and Chronic Kidney DiseaseJuly 30th, 2023- Diabetes Drug May Improve AsthmaFebruary 21st, 2023
- Medicare Reimbursement Policy for Ambulatory Blood Pressure Monitoring: A Qualitative Analysis of Public Comments to the Centers for Medicare and Medicaid ServicesDecember 1st, 2019
Grant Support
- Endogenous Aldosterone and glucose metabolismNIH/NIDDK, NHLBI2013–Present
- Role of Eicosanoids in Renal FunctionNIH/NIDDK2009–Present
- Aldosterone And Glucose MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- American Federation for Medical Research - AFMRMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
